Document ID: chunk:federal_register_of_legislation:C2024C00632:section:61:p2
Version: federal_register_of_legislation:C2024C00632
Segment Type: section
Provision Reference: s 61 (pt 2/5)
Character Range: 1131980–1134986

Territory responsible for the registration of medical practitioners in that State or Territory; and
 (c) the body in a State or Territory responsible for the registration of pharmacists in that State or Territory.
 (4) The Secretary may release to a national regulatory authority of another country, being an authority that has national responsibility relating to therapeutic goods, therapeutic goods information relating to:
 (a) recommendations of advisory committees on therapeutic goods supplied in or proposed for supply in Australia, and any conditions that are or will be applicable to that supply; or
 (b) decisions on the registration or listing, or the suspension or cancellation of the registration or listing, of therapeutic goods; or
 (baa) decisions on the inclusion of biologicals in the Register, or the suspension or cancellation of the inclusion of biologicals in the Register; or
 (ba) decisions on the inclusion of kinds of medical devices in the Register, or the suspension or cancellation of the inclusion of kinds of medical devices in the Register; or
 (c) the withdrawal from supply in Australia of therapeutic goods and the reasons for that action; or
 (d) the licensing status of Australian manufacturers of therapeutic goods and their compliance with the manufacturing principles; or
 (e) proceedings of committees established under the regulations; or
 (f) the issue of, imposition of conditions on, or revocation of, conformity assessment certificates;
for use in the performance of those functions or for furthering international co‑operation in the regulation of therapeutic goods.
 (4A) The Secretary may release to:
 (a) an authority of the Commonwealth, a State or a Territory that has functions relating to therapeutic goods, health or law enforcement; or
 (b) a national regulatory authority of another country that has national responsibility relating to therapeutic goods, health or law enforcement; or
 (ba) an international organisation that has a function relating to therapeutic goods, health or law enforcement;
therapeutic goods information relating to one or more of the following:
 (c) notifications received under section 42T;
 (d) action taken by the Secretary under Part 5‑3;
 (da) action taken by the Secretary under section 30EA (about notification and recall of therapeutic goods);
 (db) action taken by the Secretary under section 32HA (about notification and recall of biologicals);
 (dc) action taken by the Secretary under section 41KA (about notification and recall of medical devices);
 (e) contraventions, or possible contraventions, of Part 5‑2 or Part 5‑3;
 (f) any cases, or possible cases, of actual or potential tampering with therapeutic goods;
 (fa) any cases, or possible cases, of counterfeit therapeutic goods;
 (g) information relating to an offence committed against this Act, or alleged to have been committed against this Act, involving therapeutic goods;
 (h) information relating to the contravention of a civil penalty provision,